117 related articles for article (PubMed ID: 23765676)
1. Tumor targeting by a carbohydrate ligand-mimicking peptide.
Hatakeyama S; Shibata TK; Tobisawa Y; Ohyama C; Sugihara K; Fukuda MN
Methods Mol Biol; 2013; 1022():369-86. PubMed ID: 23765676
[TBL] [Abstract][Full Text] [Related]
2. Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide.
Hatakeyama S; Sugihara K; Shibata TK; Nakayama J; Akama TO; Tamura N; Wong SM; Bobkov AA; Takano Y; Ohyama C; Fukuda M; Fukuda MN
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19587-92. PubMed ID: 22114188
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate mimetic peptides as research reagent and therapeutic.
Fukuda MN; Hatakeyama S; Sugihara K
Biol Pharm Bull; 2012; 35(10):1626-32. PubMed ID: 23037151
[TBL] [Abstract][Full Text] [Related]
4. Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.
Nonaka M; Mabashi-Asazuma H; Jarvis DL; Yamasaki K; Akama TO; Nagaoka M; Sasai T; Kimura-Takagi I; Suwa Y; Yaegashi T; Huang CT; Nishizawa-Harada C; Fukuda MN
PLoS One; 2021; 16(1):e0241157. PubMed ID: 33406123
[TBL] [Abstract][Full Text] [Related]
5. Retro-inverso carbohydrate mimetic peptides with annexin1-binding selectivity, are stable in vivo, and target tumor vasculature.
Chen X; Fan Z; Chen Y; Fang X; Sha X
PLoS One; 2013; 8(12):e80390. PubMed ID: 24312470
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate binds the extracellular Annexin A1 and blocks its effects on pancreatic cancer cells.
Belvedere R; Novizio N; Pessolano E; Tosco A; Eletto D; Porta A; Campiglia P; Perretti M; Filippelli A; Petrella A
Biochem Pharmacol; 2020 Dec; 182():114252. PubMed ID: 32998001
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
8. Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells.
Li Y; Lei Y; Wagner E; Xie C; Lu W; Zhu J; Shen J; Wang J; Liu M
Bioconjug Chem; 2013 Jan; 24(1):133-43. PubMed ID: 23241015
[TBL] [Abstract][Full Text] [Related]
9. Effective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculature.
Herringson TP; Altin JG
Int J Pharm; 2011 Jun; 411(1-2):206-14. PubMed ID: 21443937
[TBL] [Abstract][Full Text] [Related]
10. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.
Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M
Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035
[TBL] [Abstract][Full Text] [Related]
11. Combination of phage display and molecular grafting generates highly specific tumor-targeting miniproteins.
Zoller F; Markert A; Barthe P; Zhao W; Weichert W; Askoxylakis V; Altmann A; Mier W; Haberkorn U
Angew Chem Int Ed Engl; 2012 Dec; 51(52):13136-9. PubMed ID: 23150222
[TBL] [Abstract][Full Text] [Related]
12. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography imaging of a novel Anxa1-targeted peptide
Chen F; Xiao Y; Shao K; Zhu B; Jiang M
J Labelled Comp Radiopharm; 2020 Oct; 63(12):494-501. PubMed ID: 32562502
[TBL] [Abstract][Full Text] [Related]
14. Potential role of Anxa1 in cancer.
Guo C; Liu S; Sun MZ
Future Oncol; 2013 Nov; 9(11):1773-93. PubMed ID: 24156336
[TBL] [Abstract][Full Text] [Related]
15. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
[TBL] [Abstract][Full Text] [Related]
16. Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis.
Bist P; Leow SC; Phua QH; Shu S; Zhuang Q; Loh WT; Nguyen TH; Zhou JB; Hooi SC; Lim LH
Oncogene; 2011 Jul; 30(28):3174-85. PubMed ID: 21383699
[TBL] [Abstract][Full Text] [Related]
17. Annexin A1 localization and its relevance to cancer.
Boudhraa Z; Bouchon B; Viallard C; D'Incan M; Degoul F
Clin Sci (Lond); 2016 Feb; 130(4):205-20. PubMed ID: 26769657
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro.
Girol AP; Mimura KK; Drewes CC; Bolonheis SM; Solito E; Farsky SH; Gil CD; Oliani SM
J Immunol; 2013 Jun; 190(11):5689-701. PubMed ID: 23645879
[TBL] [Abstract][Full Text] [Related]
20. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
